Hi-Tech Pharmacal Co., Inc. (HITK)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

369 BAYVIEW AVENUE AMITYVILLE, NY 11701

Hi-Tech Pharmacal develops, manufactures and markets generic and branded prescription and over the counter (OTC) products. Co.'s generic products are primarily prescription items and include oral solutions and suspensions, topical creams and ointments as well as nasal sprays. Co.'s Health Care Products division markets a line of OTC products for people with diabetes, including Diabetic Tussin, DiabetiDerm, Multi-betic, Mag-Ox, and DiabetiSweet, and sells the Zostrix brand of capsaicin products. Co.'s ECR Pharmaceuticals Co., Inc. subsidiary markets and distributes branded prescription pharmaceuticals that treat diseases including pain, cough/cold and allergies, and swimmer's ear.

View SEC Filings from HITK instead.

View recent insider trading info

Funds Holding HITK (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding HITK BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DURRANT CAMERON CHIEF EXECUTIVE OFFICER

0 2020-05-20 0

PETERS WILLIAM J CFO, SVP & TREASURER

  • Officer
104,038 2020-03-16 0

CASKEY DAVIS S

  • Director
229,892 2018-02-26 0

VAN HULST JACK

  • Director
No longer subject to file 2014-05-16 0

APRIL GARY M PRESIDENT, HCP DIVISION

  • Officer
0 2013-12-13 0

SELTZER REUBEN VICE CHAIRMAN, BUSINESS DEV'T

  • Officer
  • Director
824,068 2013-10-10 0

SELTZER DAVID S CEO, PRESIDENT, SEC'Y, TREAS.

  • Officer
  • Director
  • 10% Owner
1,564,539 2013-10-08 0

GOLDWYN MARTIN M

  • Director
0 2013-10-04 0

SIMPSON BRUCE W

  • Director
0 2013-10-01 0

HIRSHAUT YASHAR

  • Director
56,750 2013-09-17 0

EGBARIA KAMEL CHIEF SCIENTIFIC OFFICER, EVP

  • Officer
0 2013-05-22 0

PUGLISI ANTHONY J

  • Director
0 2012-11-07 0

FLYNN JAMES E

DEERFIELD CAPITAL LP

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD PARTNERS, LP

DEERFIELD MANAGEMENT CO /NY

DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LTD

DEERFIELD INTERNATIONAL LTD

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2011-05-26 0

FLYNN JAMES E

DEERFIELD CAPITAL LP

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD MANAGEMENT CO /NY

DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LTD

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2011-03-18 0

HARVEY BRYCE M OFFICER

  • Officer
0 2010-11-10 0

ACCIPITER CAPITAL MANAGEMENT, LLC

ACCIPITER LIFE SCIENCES FUND II L P

ACCIPITER LIFE SCIENCES FUND II OFFSHORE LTD

ACCIPITER LIFE SCIENCES FUND II QP L P

ACCIPITER LIFE SCIENCES FUND LP

ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD

CANDENS CAPITAL LLC

HOFFMAN GABE

  • 10% Owner
  • (SEE FOOTNOTE 1)
No longer subject to file 2009-02-06 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

Elevate your investments